14 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $271M | -$390M | 17.0% | -139.5% | -$5M | $65M | $157M |
| 2024 | $453M | $13M | 40.4% | 12.0% | -$41M | $115M | $221M |
| 2023 | $239M | -$46M | 23.8% | -20.6% | -$218M | — | $140M |
| 2022 | $180M | -$83M | 2.8% | -43.9% | -$272M | — | $281M |
| 2021 | $122M | -$37M | 8.2% | -33.4% | -$32M | — | $77M |
| 2020 | $100M | -$22M | 14.6% | -21.5% | -$13M | $4M | $16M |
| 2019 | $139M | -$15M | 18.9% | -10.2% | -$3M | — | $4M |
| 2018 | $104M | -$34M | 12.1% | -32.5% | -$12M | — | $3M |
| 2017 | $112M | -$19M | 16.7% | -17.1% | -$11M | — | $11M |
| 2016 | $118M | -$12M | 19.8% | -9.5% | -$14M | — | $18M |
| 2015 | — | -$6M | — | — | — | — | $33M |
| 2014 | — | -$66M | — | — | — | — | $50M |
| 2013 | — | -$48M | — | — | — | — | $2M |
| 2012 | — | -$56M | — | — | — | — | $1M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $38M | -$24M | 11.3% | -55.0% | $33M | $61M | $174M |
| Dec '25 | $41M | -$73M | -55.5% | -170.3% | $14M | $65M | $157M |
| Sep '25 | $73M | -$6M | 28.5% | -4.6% | $6M | $96M | $151M |
| Jun '25 | $78M | -$9M | 32.4% | -6.6% | -$17M | $103M | $168M |
| Mar '25 | $79M | -$301M | 29.0% | -380.2% | -$7M | $109M | $192M |
| Dec '24 | $123M | $11M | 38.3% | 12.0% | $21M | $115M | $221M |
| Sep '24 | $117M | -$13M | 41.8% | 14.8% | -$50000 | $120M | $113M |
| Jun '24 | $118M | $17M | 43.8% | 17.0% | -$18M | — | $91M |
| Mar '24 | $95M | -$2M | 37.2% | 2.6% | -$44M | — | $101M |
| Dec '23 | $84M | -$519000 | 35.2% | 1.6% | -$31M | — | $140M |
| Sep '23 | $61M | -$13M | 22.7% | -24.1% | -$40M | — | $95M |
| Jun '23 | $48M | -$15M | 17.5% | -35.4% | -$74M | — | $134M |
| Mar '23 | $46M | -$17M | 11.2% | -41.5% | -$74M | — | $208M |
| Dec '22 | $60M | -$10M | 24.0% | -16.2% | -$83M | — | $281M |
| Sep '22 | $37M | -$30M | -17.3% | -77.1% | -$104M | — | $102M |
| Jun '22 | $46M | -$24M | -2.7% | -49.6% | -$48M | — | $162M |
| Mar '22 | $38M | -$19M | -4.7% | -48.5% | -$37M | — | $205M |
| Dec '21 | $31M | -$16M | -5.3% | -51.8% | -$20M | — | $77M |
| Sep '21 | $30M | -$8M | 10.1% | -37.8% | -$8M | — | $96M |
| Jun '21 | $32M | -$7M | 14.5% | -20.9% | -$1M | $4M | $102M |
How the market has priced ASPN against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Aspen Aerogels Inc's revenue has grown 22.0% per year. These are computed facts, not advice.
As of FY2025, Aspen Aerogels Inc reported $65M of total debt against $157M of cash.
In FY2025, gross margin was 17.0%, operating margin -139.5%, and net margin -143.7%.
As of Jun '26, Aspen Aerogels Inc traded at a price-to-earnings ratio of about 20.0× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.